Court documents show trail of deception on Celebrex

Get news, sports and politics alerts

Click here to manage your alerts

Research» Pfizer defends decision to release partial results about drug’s safety.

< Previous Page

This article cannot be shown due to contract restrictions.

Photos

View photo gallery (3 photos)

At a glance

—

In Utah

Brigham Young University and professor Daniel Simmons sued Pfizer in 2006, saying Simmons had made a critical discovery that led to the development of Celebrex but that he and BYU had been denied a share of profits. Pfizer agreed to settle the case earlier this year for $450 million. That lawsuit was not associated with a pending securities fraud case against Pfizer.

	Join the Discussion
	Post a Comment

In veto-proof vote, Salt Lake City Council OK’s $8M tax increase
Published Jun 18, 2013 04:25:02PM
Weber voters to decide $45 million library bond
Published Jun 18, 2013 04:23:02PM

Top Reader Comments • Read All Comments • Post a Comment

Click here to read all comments Click here to post a comment

About Reader Comments

Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account.
See more about comments here.

Popular Stories